OKYO Pharma Limited (NASDAQ:OKYO)’s traded shares stood at 81427.0 during the last session, with the company’s beta value hitting -0.10. At the close of trading, the stock’s price was $2.78, to imply a decrease of -4.47% or -$0.13 in intraday trading. The OKYO share’s 52-week high remains $3.11, putting it -11.87% down since that peak but still an impressive 70.86% since price per share fell to its 52-week low of $0.81. The company has a valuation of $104.03M, with an average of 0.14 million shares in intraday trading volume over the past 10 days and average of 154.97K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for OKYO Pharma Limited (OKYO), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give OKYO a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.
OKYO Pharma Limited (NASDAQ:OKYO) trade information
After registering a -4.47% downside in the last session, OKYO Pharma Limited (OKYO) has traded red over the past five days. The 5-day price performance for the stock is 14.64%, and 48.66% over 30 days. With these gigs, the year-to-date price performance is 124.19%. Short interest in OKYO Pharma Limited (NASDAQ:OKYO) saw shorts transact 0.19 million shares and set a 0.8 days time to cover.
OKYO Dividends
OKYO Pharma Limited has its next earnings report out in August. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
OKYO Pharma Limited (NASDAQ:OKYO)’s Major holders
OKYO Pharma Limited insiders hold 34.41% of total outstanding shares, with institutional holders owning 6.13% of the shares at 9.35% float percentage. In total, 6.13% institutions holds shares in the company.